|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||27.62 - 27.62|
|52-week range||27.62 - 27.62|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||N/A|
|Earnings date||25 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Neal Walker became the CEO of Aclaris Therapeutics, Inc. (NASDAQ:ACRS) in 2012, and we think it's a good time to look...
The big shareholder groups in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) have power over the company. Institutions often...